EUCTR2008-005951-84-AT进行中（未招募）1 期
Treat-to-target trial of basal insulin in Post-Transplant Hyperglycemia (TIP): Efficacy and safety of a novel protocol in renal transplant recipients receiving a tacrolimus-based immunosupprerssion - TIP
Medizinische Universität Wien, KIM III, Abteilung für Nephrologie0 个研究点目标入组 50 人开始时间: 2008年10月27日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Renal transplantation and immunosuppression with the standard protocol of our center (tacrolimus, mycophenolate mofetil, prednisone triple therapy without any induction therapy)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any history of Diabetes Mellitus is an exclusion criterion.
研究者
相似试验
已完成
2 期
Treat-to-target Trial of Basal Insulin in Post-transplant HyperglycemiaHyperglycemiaNCT00830297Marcus Saemann50
已完成
4 期
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyType 2 Diabetes MellitusNCT03359837Sanofi384
进行中（未招募）
不适用
A Randomized Trial Comparing either Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects with Type 2 Diabetes who were previously treated by basal insulin Glargine with either metformin or metformin and sulfonylurea - NDMedDRA version: 9.1Level: LLTClassification code 10012594Type 2 DiabetesEUCTR2009-009500-39-ITELI LILLY760
已完成
4 期
Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mLType I Diabetes MellitusNCT03406000Sanofi170
招募中
不适用
The comparison of basal insulin therapy with average daily risk range (ADRR).Patients with diabetes melliutusJPRN-UMIN000019886MACHIDA MUNICIPAL HOSPITA100